Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Clin Breast Cancer. 2018 Mar 15;18(5):387–394. doi: 10.1016/j.clbc.2018.03.010

Figure 4. A, B, C Predictive Biomarkers of Benefit from Paclitaxel and Dasatinib.

Figure 4

Figure 4

NTX; Collagen Type IV or N-telopeptide,

VEGF; vascular epidermal growth factor receptor 2

CTC; circulating tumor cells

Box and Whisker plots comparing median (horizontal line), interquartile range (shaded box) and range